Archive: 15/11/2017

Mepsevii approved for rare enzyme disorder

(HealthDay)—Mepsevii (vestronidase alfa-vjbk) has been approved by the U.S. Food and Drug Administration to treat a rare, genetic disorder called mucopolysaccharidosis type VII, sometimes called Sly syndrome.

page 2 from 11